Evidence-based treatment for vasovagal syncope

Heart Rhythm

Volumn 5, Issue 11, 2008, Pages 1609-1614

  Kuriachan, Vikas ^a   Sheldon, Robert S ^a   Platonov, Michael ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUDROCORTISONE; FLUOXETINE; INFUSION FLUID; METOPROLOL; MIDODRINE; NADOLOL; PLACEBO; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE;

ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD VOLUME; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DRUG DOSE TITRATION; DRUG EFFECT; DRUG ERUPTION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FLUID INTAKE; HEART OUTPUT; HEART PACING; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; NAUSEA; PARESTHESIA; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRESYNCOPE; PRIORITY JOURNAL; REFLEX; SALT INTAKE; SIDE EFFECT; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TILTING; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; FLUDROCORTISONE; HUMANS; MIDODRINE; PACEMAKER, ARTIFICIAL; SEROTONIN UPTAKE INHIBITORS; SYNCOPE, VASOVAGAL; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 57149146317     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.08.023     Document Type: Article

References (25)

1. Serletis A., Rose S., Sheldon A.G., et al. Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J 27 (2006) 1965-1970
2. Ganzeboom K.S., Colman N., Reitsma J.B., et al. Prevalence and triggers of syncope in medical students. Am J Cardiol 91 (2003) 1006-1008
3. Sheldon R.S., Sheldon A.G., Connolly S.J., et al., Investigators of the Syncope Symptom Study and the Prevention of Syncope Trial. Age of first faint in patients with vasovagal syncope. J Cardiovasc Electrophysiol 17 (2006) 49-54
4. Van Dijk N., Boer K.R., Colman N., et al. High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: The Fainting Assessment Study. J Cardiovasc Electrophysiol 19 (2008) 48-55
5. Sheldon R., Morillo C.A., and Krahn A. Management of vasovagal syncope: 2004. Expert Rev Cardiovas Ther 2 (2004) 915-923
6. Gardenghi G., Rondon M.U.P.B., Braga A.M.F.W., et al. The effects of exercise training on arterial baroreflex sensitivity in neurally mediated syncope patients. Eur Heart J 28 (2007) 2749-2755
7. van Dijk N., de Bruin I.G., Gisolf J., et al. Hemodynamic effects of leg crossing and skeletal muscle tensing during free standing in patients with vasovagal syncope. J Appl Physiol 98 (2005) 584-590
8. Krediet C.T., van Lieshout J.J., Bogert L.W., et al. Leg crossing improves orthostatic tolerance in healthy subjects: a placebo-controlled crossover study. Am J Physiol Heart Circ Physiol 291 (2006) H1768-H1772
9. van Dijk N., Quartieri F., Blanc J.J., et al., PC-Trial Investigators. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol 48 (2006) 1652-1657
10. Ector H., Willems R., Heidbuchel H., et al. Repeated tilt testing in patients with tilt positive neurally mediated syncope. Europace 7 (2005) 628-633
11. Abe H., Kohshi K., and Nakashima Y. Efficacy of orthostatic self-training in medically refractory neurocardiogenic syncope. Clin Exp Hypertension 25 (2003) 487-493
12. Kinay O., Yazici M., Nazli C., et al. Tilt training for recurrent neurocardiogenic syncope. Jpn Heart J 45 (2004) 833-845
13. Foglia-Manzillo G., Giada, Gaggioli G., et al. Efficacy of tilt training in the treatment of neurally-mediated syncope. A randomized study. Fr. Europace 6 (2004) 199-204
14. Dugyu H., Zoghi M., Turk U., et al. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study. PACE 31 (2008) 592-596
15. On Y.K., Park J., Huh J., et al. Is home orthostatic self-training effective in preventing neurally mediated syncope?. PACE 30 (2007) 638-643
16. Sheldon R., Connolly S., Rose S., et al., POST Investigators. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113 (2006) 1164-1170
17. Theodorakis G.N., Leftheriotis D., Livanis E.G., et al. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace 8 (2006) 193-198
18. Qingyou Z., Junbao D., and Chaoshu T. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope. J Pediatr 149 (2006) 777-780
19. Salim M.A., and Di Sessa T.G. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol 45 (2005) 484-488
20. Raj S.R., Rose S., Ritchie D., et al., POST II Investigators. The Second Prevention of Syncope Trial (POST II)-a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J 151 (2006) 1186 e11-1186.e17
21. Connolly S.J., Sheldon R., Thorpe K.E., et al. The Second Vasovagal Pacemaker Study (VPSII): a double-blind randomized controlled trial of pacemaker therapy for the prevention of syncope in patients with recurrent severe vasovagal syncope. JAMA 290 (2003) 1579-1580
22. Raviele A., Giada F., Menozzi C., et al., Vasovagal Syncope and Pacing Trial Investigators. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 25 (2004) 1741-1748
23. Sud S., Massel D., Klein G.J., et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med 120 (2007) 54-62
24. Brignole M., Sutton R., Menozzi C., et al., International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 27 (2006) 1085-1092
25. Brignole M. International study on syncope of uncertain aetiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design. Europace 9 (2007) 25-30